reports
- GlobalData Healthcare Department
Solasia Pharma KK (4597) - Financial Analysis Review
Solasia Pharma KK (4597) - Financial Analysis Review Summary Solasia Pharma KK (Solasia Pharma) formerly JapanBridge Inc is a healthcare service provider that provides patient access to Western oncology therapies. The company develops and commercializes oncology therapies and cancer supportive care products. Its products include transdermal system which delivers the anti-emetic and granisetron in the patient’s bloodstream without the need for injections and swallowing pills. GlobalData's So...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.